The medical evaluation includes: Review of your health history, including current medications, medical conditions, allergies, and previous weight loss attempts Assessment of your eligibility for GLP-1 therapy based on BMI, health conditions, and contraindications Discussion of treatment options, expected outcomes, potential side effects, and risks Determination of the appropriate medication (semaglutide or tirzepatide), starting dose, and titration schedule A prescription written by a licensed healthcare provider (physician, nurse practitioner, or physician assistant) who has determined that GLP-1 therapy is medically appropriate for you This evaluation can occur in-person with your primary care provider or specialist, or via a telehealth platform like FormBlends
(PubMed) Yu SY, Zhu YJ, Li WG
In Australia, these are not legally available for therapeutic use
Most patients maintain therapeutic benefit at doses between 1.0 mg and 2.4 mg weekly, though some achieve their goals at lower levels
: , BPC-157 QTc ,